Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Fredun Pharmaceuticals had annual revenue of 6.39B INR with 40.83% growth. Fredun Pharmaceuticals had revenue of 2.13B in the quarter ending March 31, 2026, with 29.16% growth.

• Revenue: 6.39B
• Revenue Growth: +40.83%
• P/S Ratio: 2.07
• Revenue / Employee: 24.49M
• Employees: 261
• Market Cap: 13.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.39B	1.85B	40.83%
Mar 31, 2025	4.54B	1.06B	30.35%
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error